Unexpectedly High Efficacy of SARS-CoV-2 BNT162b2 Vaccine in Liver versus Kidney Transplant Recipients—Is It Related to Immunosuppression Only?

Unexpectedly High Efficacy of SARS-CoV-2 BNT162b2 Vaccine in Liver versus Kidney Transplant Recipients—Is It Related to Immunosuppression Only?

The BNT162b2 vaccine is reportedly effective in preventing severe disease in more than 90% of the general population, but its efficacy in transplant recipients remains controversial. We aimed to determine the immune response to the BNT162b2 vaccine in kidney (KTRs) and liver transplant recipients (L...

Full description

Bibliographic Details
Main Authors: Paulina Nazaruk, Marta Monticolo, Anna Maria Jędrzejczak, Natalia Krata, Barbara Moszczuk, Joanna Sańko-Resmer, Tomasz Pilecki, Arkadiusz Urbanowicz, Michał Florczak, Leszek Pączek, Bartosz Foroncewicz, Krzysztof Mucha
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:Vaccines
Subjects:
BNT162b2 mRNA
COVID-19
kidney transplantation
liver transplantation
SARS-CoV-2
SOT
Online Access:https://www.mdpi.com/2076-393X/9/12/1454

Internet

https://www.mdpi.com/2076-393X/9/12/1454

Similar Items